Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00843882 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

StatusActive, Not Recruiting
PhasePhase 3
Started2009-04-20
View on ClinicalTrials.gov ↗

Amendment history

The 50 most recent of 1126 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

2026-09-01
Study Status, Contacts/Locations v1125
Completion pushed: 2026-10-02 → 2027-05-28
Study sites507 entries, revised
Kaiser Permanente-Rio San Diego Mission
2026-08-11
Study Identification, Study Status, Eligibility, Contacts/Locations, Participant Flow v1124
Completion date2026-10-02→2027-05-28
Start date2009-01-29→2009-04-20
Study sites508→507
Eligibility criteria-22 characters
[...] of childbearing potential (FCBP) is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the f [...]
2026-05-28
Study Status, Contacts/Locations v1123
Study sites508 entries, revised
CommonSpirit Saint Anthony Hospital Saint Michael Cancer Center Saint Joseph Medical Center Hematology and Oncology - Silverdale
2026-04-30
Study Status, Contacts/Locations v1122
Study sitesdetails revised at 1 of 508 sites
2026-04-09
27 amendments v1095-v1121
27 re-verifications since 2026-03-04, no change to tracked fields
Show 19 earlier versions
2026-02-11
Study Status, Contacts/Locations v1094
Study sites508 entries, revised
University of Michigan ComprehensiveRogel Cancer Center UNC RexHealth HealthcareCancer Care Raleigh UNC RexHealth Cancer Center ofCare Wakefield ThompsonCovenant Health Cancer Survival CenterCenters
2025-11-14
Study Status, Contacts/Locations v1093
Study sites508 entries, revised
Banner McKeeNorth Colorado Medical Center - Loveland Campus
2025-10-03
Study Status v1092
Completion date2025-10-02→2026-10-02
2025-08-02
Study Status, Contacts/Locations v1091
Study sites508 entries, revised
AscensionBeacon Borgess HospitalKalamazoo
2025-07-25
Study Status, Contacts/Locations v1090
Study sites508 entries, revised
Boulder Community Foothills Hospital
2025-07-08
Study Status, Contacts/Locations v1089
Study sites508 entries, revised
PhoenixvilleReading Hospital McGlinn Cancer Institute at Phoenixville
2025-06-21
Study Status, Contacts/Locations v1088
Study sites508 entries, revised
StewardDana-Farber SaintCancer Elizabeth'sInstitute at Boston Medical Center - Brighton
2025-05-09
Study Status, Contacts/Locations v1087
Study sites508 entries, revised
Liberty Radiation Oncology CenterHospital
2025-04-03
Study Identification, Study Status, Contacts/Locations v1086
Study sites508 entries, revised
AdventHealth Littleton AdventHealth AdventistParker UI Hospital ParkerHealth AdventistCare Hospital Mission Cancer and Blood - West Des Moines Clinic UI Health Care Mission Cancer and Blood - Des Moines Clinic UI Health Care Mission Cancer and Blood - Laurel Clinic Advent Health -AdventHealth Shawnee Mission Medical Center SoutheastMercy Cancer Center - Cape Girardeau
2025-02-05
Study Status, Contacts/Locations v1085
Study sites508 entries, revised
AdventHealth Porter Adventist Hospital
2025-01-17
Study Status, Contacts/Locations v1084
Study sites508 entries, revised
HarrisonSaint HealthPartnersMichael HematologyCancer and Oncology-BremertonCenter
2024-12-21
Study Status, Contacts/Locations v1083
Study sites508 entries, revised
SCL Health Saint Joseph Hospital - Cancer Centers of Colorado
2024-11-09
Study Status, Contacts/Locations v1082
Completion date2024-09-21→2025-10-02
Study sites513→508
2024-09-25
Study Status, Contacts/Locations v1081
Study sites513 entries, revised
SCLIntermountain Health Lutheran Medical CenterHospital
2024-09-03
Study Status, Conditions v1080
Re-verified, no change to tracked fields
2024-08-15
Study Status, Contacts/Locations v1079
Study sites513 entries, revised
AscensionMyMichigan SaintMedical Mary'sCenter HospitalSaginaw
2024-07-10
Study Status, Arms and Interventions, Contacts/Locations v1078
Study sites513 entries, revised
BeaumontCorewell Health Dearborn Hospital - Dearborn
2024-06-26
Study Status, Contacts/Locations v1077
Study sites513 entries, revised
WilliamCorewell Health Beaumont Troy Hospital - Troy
2024-06-06
Study Status, Contacts/Locations v1076
Study sites513 entries, revised
University of Wisconsin Carbone Cancer Center - Johnson Creek
This randomized phase III trial studies lenalidomide to see how well it works with or without epoetin alfa in treating patients with myelodysplastic syndrome and anemia. Lenalidomide may stop the growth of myelodysplastic syndrome by blocking blood flow to the cells. Colony stimulating factors, such as epoetin alfa, may increase the number of immune cells found in bone marrow or peripheral blood. It is not yet known whether lenalidomide is more effective with or without epoetin alfa in treating patients with myelodysplastic syndrome and anemia.
Trial Details
NCT Number NCT00843882
Lead Sponsor National Cancer Institute (NCI)
Conditions Anemia, Chronic Myelomonocytic Leukemia, De Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome
Enrollment 247 participants
Start Date 2009-04-20
Primary Completion 2019-07-08 (estimated)
Study Completion 2027-05-28 (estimated)
Updated on ClinicalTrials.gov 2026-10-01